Professor Richard Scolyer AO, BMedSci, MBBS, MD, FRCPA, FRCPath, FAHMSis Senior Staff Specialist, Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney; Co- Medical Director, Melanoma Institute Australia; and Conjoint Professor, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney. He provides a clinical consultation service for the diagnosis of difficult pigmented lesions and receives more than 2000cases for opinion from Australasia and beyond annually. Richard effectively integrates his clinical practice with co-leading an award-winning translational melanoma research laboratory. His record includes co-authoring more than 916 peer reviewed publications, books and/or book-chapters including in prestigious journals such as New England Journal of Medicine, Lancet, Nature, Cell, Nature Genetics, Lancet Oncology, Journal of Clinical Oncology, Journal of the National Cancer Institute and Cancer Discovery with >78,176 citations and a H-index of 130 (Google Scholaras at 28 September 2023). Richard has presented on more than 430 occasions at conferences throughout the world. In August 2023, he was notified that he had been selected to receive the Society for Melanoma Research (SMR) 2023 Lifetime Achievement Award. In May 2023, he received the International Academy of Pathology’s “Distinguished Pathology Award” for his outstanding contribution to the discipline of anatomical pathology.